This site is intended for Healthcare Professionals only.

UK orders millions more antivirals to help fight Omicron


Share post:

With growing concerns over the spread of Omicron variant, the UK has signed two contracts with drug majors Pfizer Inc. and Merck & Co to buy 4.25 million courses of antivirals for the NHS patients.

The move is aimed at reducing hospitalisations and easing pressures on the NHS.

The two new contracts are for 1.75 million additional courses of Merck Sharp and Dohme’s (MSD) molnupiravir (Lagevrio®) and 2.5 million additional courses of PF-07321332/ritonavir (Paxlovid™) from Pfizer.

The ordered drugs will be available from early next year and both are expected to be effective against Omicron.

The recent order is in addition to the 480,000 courses of molnupiravir and 250,000 courses of PF-07321332/ritonavir procurement announced in October.

Health secretary Sajid Javid

Commenting on the new contracts, health and social care secretary Sajid Javid, said: “This is a mammoth deal for the UK government and for patients across the country that are set to benefit from these antivirals over the coming months.”

Javid said the latest move is to further efforts to bolster response to the virus “by ensuring access to the world’s best treatments”.

He further urged people aged 50 and over with an underlying health condition and tested positive for Covid-19 to sign up for the study and take advantage of this remarkable treatment.

Molnupiravir is already being rolled out to hundreds of patients through the national study PANORAMIC, run by the University of Oxford in close collaboration with GP hubs.

Targeting the virus at an early stage, antivirals are used to treat the infected people or protect exposed individuals from becoming infected.

Chair of the Antivirals Taskforce Eddie Gray said: “Both antivirals in our current portfolio could be vital tools against Omicron, with current evidence showing they will be effective against the variant.

The Antivirals Taskforce will continue its work to ensure vulnerable people who test positive for Covid-19 can rapidly access these medicines.”


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

NHS patient safety initiative: 143 hospitals across England to roll out Martha’s Rule

This programme has the opportunity to truly transform “patient care and safety” NHS England has confirmed the initial sites...

RPS joins efforts to boost children’s health in Wales

A group of 20 royal colleges and professional bodies unite to elevate the profile of child health in...

SSPs reactivated for clarithromycin amid surging whooping cough cases

The UK Health Security Agency (UKHSA) has confirmed 2,793 cases of whooping in the first quarter of 2024,...

Insect bites and stings surge: Searches for NHS advice triple

Visit your local pharmacy for advice and treatment of common health conditions, including infected insect bites Insect bites...